User:Mr. Ibrahem/Pegvaliase
![]() | |
Clinical data | |
---|---|
Pronunciation | peg val' i ase |
Trade names | Palynziq |
Other names | Pegvaliase-pqpz; PEG-PAL; RAvPAL-PEG |
AHFS/Drugs.com | Monograph |
License data |
|
Pregnancy category |
|
Routes of administration | Subcutaneous |
Drug class | Enzyme[2] |
Legal status | |
Legal status | |
Identifiers | |
| |
Chemical and physical data | |
Formula | C15H30N2O5 |
Molar mass | 318.414 g·mol−1 |
3D model (JSmol) | |
| |
|
Pegvaliase, sold under the brand name Palynziq, is a medication used to treat phenylketonuria.[2] It is used when other treatments, including diet and sapropterin, are not sufficient.[2][3] It is given by injection under the skin.[3]
Common side effects include pain at the site of injection, joint pain, and allergic reactions.[2] Other side effects may include anaphylaxis, angioedema, and serum sickness.[2][3] It is unclear if use during pregnancy is safe for the baby.[3] It is the enzyme phenylalanine ammonia lyase connected to polyethylene glycol and works by breaking down phenylalanine.[2][3]
Pegvaliase was approved for medical use in the United States in 2018 and Europe in 2019.[3][2] It is not available in the United Kingdom as of 2021.[4] In the United States it costs about 560 USD per dose up to 20 mg as of 2021.[5]
References[edit]
- ^ a b "Palynziq". Therapeutic Goods Administration (TGA). 23 July 2021. Archived from the original on 5 September 2021. Retrieved 5 September 2021.
- ^ a b c d e f g h i "Palynziq". Archived from the original on 20 October 2021. Retrieved 27 October 2021.
- ^ a b c d e f "Pegvaliase-pqpz Monograph for Professionals". Drugs.com. Retrieved 27 October 2021.
- ^ "Pegvaliase". SPS - Specialist Pharmacy Service. 31 March 2015. Archived from the original on 27 October 2021. Retrieved 27 October 2021.
- ^ "Palynziq Prices, Coupons & Patient Assistance Programs". Drugs.com. Archived from the original on 26 January 2021. Retrieved 27 October 2021.